Cronos Group Inc vs Invesco S&P 500 Low Volatility ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Invesco S&P 500 Low Volatility ETF trades at $72.2 (market cap $6.94B). The key difference: Invesco S&P 500 Low Volatility ETF is far larger — about 5.9× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Invesco S&P 500 Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Invesco S&P 500 Low Volatility ETF for 123 Days on average.
| CRON | SPLV | |
|---|---|---|
Market Cap | $1.18B | $6.94B |
Volume | 968,037 | 1,663,703 |
Sector | Health | — |
52-Week High | $3.55 | $77.97 |
52-Week Low | $2.30 | $70.30 |
Typical Hold Time | 22 Days | 123 Days |
Enterprise Value | $387.62M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $146.59M in 2025, but net income was -$9.45M. Recent Q2 2026 earnings beat expectations with EPS of $0.09. The company held its first Investor Day in September 2026, highlighting international expansion and cash flow focus.
Outlook is mixed: strong revenue growth and a solid balance sheet with no debt support upside, but profitability remains inconsistent. Risks include cash flow volatility and competitive pressures. Analyst consensus is cautious with 60% hold ratings, reflecting uncertainty amid expansion efforts.
SPLV, the Invesco S&P 500 Low Volatility ETF, trades at $72.17 with a 1.33% daily gain. The ETF faces technical headwinds with a bearish moving average signal while oscillators remain neutral. Recent news highlights SPLV's underperformance versus the S&P 500, returning 5% versus 17%, due to sector overweights in Utilities, Real Estate, and Financials. The ETF maintains a 19.5x P/E ratio with upcoming dividend payments scheduled.
SPLV offers defensive exposure during market volatility but faces growth-adjusted valuation concerns. Key risks include concentrated sector exposure and lagging broad market performance. The neutral technical stance and mixed sentiment suggest cautious positioning for investors seeking low-volatility equity exposure amid geopolitical and economic uncertainty.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →